There is promising news across the pond for coronavirus therapeutics. A U.K. based drug company is seeing positive results out of a small experimental trial in hospitalized coronavirus patients for a potential treatment, giving people a glimmer of hope throughout the world. FOX's Trey Yingst speaks with Richard Marsden, the CEO of Synairgen, on how the treatment drug works.